EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Clinical and genetic features of CMT2T in Italian patients confirm the importance of MME pathogenic variants in idiopathic, late‐onset axonal neuropathies

Alessandro Geroldi iD, Andrea La Barbera, Alessia Mammi iD, Paola Origone, Andrea Gaudio, Clarissa Ponti, Francesca Sanguineri, Sabrina Matà, Martina Sperti, Ilaria Carboni, Emilia Bellone, Fabio Gotta und 14 weitere

Journal of the Peripheral Nervous System · 2024

DOI: 10.1111/jns.12657 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the Peripheral Nervous System, 2024. Verfasst von Alessandro Geroldi und 25 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosciences, Rehabilitation, Ophthalmology, Genetic and Maternal and Infantile Sciences, Università di Genova, Genoa, Italy. Hauptthemen laut MEDLINE: Charcot-Marie-Tooth Disease. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Since 2016, biallelic mutations in the membrane metalloendopeptidase ( MME) gene have been associated with late‐onset recessive CMT2 (CMT2T). More recently, heterozygous mutations have also been identified in familial and sporadic patients with late‐onset axonal neuropathy, ranging from subclinical to severe. This indicates that the heterozygous MME variants may not be fully penetrant, or alternatively, that they may be a potential risk factor for neuropathy. Here, we describe the clinical, neurophysiological, and genetic findings of 32 CM2T Italian patients.

Methods

The patients were recruited from four different Italian referral centers. Following a comprehensive battery of neurological, electrophysiological, and laboratory examinations, the patients' DNA was subjected to sequencing in order to identify any variants in the gene. Bioinformatic and modeling analyses were performed to evaluate the identified variants' effects.

Results

We observe a relatively mild axonal sensory‐motor neuropathy with a greater impairment of the lower extremities. Biallelic and monoallelic patients exhibit comparable disease severity, with an earlier onset observed in those with biallelic variants. When considering a subgroup with more than 10 years of disease, it becomes evident that biallelic patients exhibit a more severe form of neuropathy. This suggests that they are more prone to quick progression.

Interpretation

CM2T has been definitively defined as a late‐onset neuropathy, with a typical onset in the fifth to sixth decades of life and a more rapidly progressing worsening for biallelic patients. CMT2T can be included in the neuropathies of the elderly, particularly if MME variants heterozygous patients are included.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Charcot-Marie-Tooth DiseaseHumansFemaleMaleItalyMiddle AgedAdultAgedAge of OnsetMutationMetalloendopeptidases

Stichwörter der Autor:innen

CMTMMEgenotype–phenotype correlationlate‐onset peripheral neuropathiesneprilysin

Substanzen

Metalloendopeptidases

Autor:innen und Institutionen

  • Department of Neurosciences, Rehabilitation, Ophthalmology, Genetic and Maternal and Infantile Sciences, Università di Genova, Genoa, Italy.
  • OU Medical Genetics, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
  • Neurology Unit, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.
  • SOD Diagnostica Genetica, Forensic Genetic Unit, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.
  • OU Neurology Clinic, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
  • Department of Neuroscience, Sense Organs and Chest, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.

ORCID-Profile: Alessandro Geroldi, Alessia Mammi, Lucio Marinelli, Giulia Bisogni, Stefano Tozza

Zitieren

APA

Geroldi, A., La Barbera, A., Mammi, A., Origone, P., Gaudio, A., Ponti, C., Sanguineri, F., Matà, S., Sperti, M., Carboni, I., Bellone, E., Gotta, F., Gemelli, C., Massucco, S., Valeria, G., Marinelli, L., Grandis, M., Bisogni, G., Sabatelli, M., …, & Luigetti, M. (2024). Clinical and genetic features of CMT2T in Italian patients confirm the importance of MME pathogenic variants in idiopathic, late‐onset axonal neuropathies. Journal of the Peripheral Nervous System. https://doi.org/10.1111/jns.12657

Vancouver

Geroldi A, La Barbera A, Mammi A, Origone P, Gaudio A, Ponti C, et al. Clinical and genetic features of CMT2T in Italian patients confirm the importance of MME pathogenic variants in idiopathic, late‐onset axonal neuropathies. Journal of the Peripheral Nervous System. 2024. doi:10.1111/jns.12657

BibTeX
@article{Geroldi2024,
  author = {Geroldi, Alessandro and La Barbera, Andrea and Mammi, Alessia and Origone, Paola and Gaudio, Andrea and Ponti, Clarissa and Sanguineri, Francesca and Matà, Sabrina and Sperti, Martina and Carboni, Ilaria and Bellone, Emilia and Gotta, Fabio and Gemelli, Chiara and Massucco, Sara and Valeria, Guglielmino and Marinelli, Lucio and Grandis, Marina and Bisogni, Giulia and Sabatelli, Mario and Piscosquito, Giuseppe and Esposito, Gabriella and Schenone, Angelo and Manganelli, Fiore and Mandich, Paola and Tozza, Stefano and Luigetti, Marco},
  title = {Clinical and genetic features of CMT2T in Italian patients confirm the importance of MME pathogenic variants in idiopathic, late‐onset axonal neuropathies},
  journal = {Journal of the Peripheral Nervous System},
  year = {2024},
  doi = {10.1111/jns.12657}
}
Kostenlos starten →